Welcome to LookChem.com Sign In|Join Free
  • or
6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one is a chemical compound with the molecular formula C10H8ClN3O2. It is a yellow crystalline powder that serves as an intermediate in the synthesis of pharmaceuticals, specifically as an intermediate for Eszopiclone, a sedative-hypnotic drug used to treat insomnia.

43200-81-3

Post Buying Request

43200-81-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

43200-81-3 Usage

Uses

Used in Pharmaceutical Industry:
6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one is used as an intermediate in the synthesis of Eszopiclone, a sedative-hypnotic drug. It plays a crucial role in the production process, contributing to the development of medications that help alleviate insomnia and improve sleep quality.
Additionally, it is also used as an impurity in the manufacturing of Eszopiclone. Understanding and controlling the presence of this impurity is essential for ensuring the safety, efficacy, and quality of the final drug product.
Chemical Properties:
6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one is characterized as a yellow crystalline powder. Its chemical structure and properties make it suitable for use in the pharmaceutical industry, particularly in the synthesis of Eszopiclone and related compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 43200-81-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,3,2,0 and 0 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 43200-81:
(7*4)+(6*3)+(5*2)+(4*0)+(3*0)+(2*8)+(1*1)=73
73 % 10 = 3
So 43200-81-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H7ClN4O2/c12-6-1-2-7(15-5-6)16-10(17)8-9(11(16)18)14-4-3-13-8/h1-5,10,17H

43200-81-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (Y0001822)  Zopiclone impurity B  EuropePharmacopoeia (EP) Reference Standard

  • 43200-81-3

  • Y0001822

  • 1,880.19CNY

  • Detail

43200-81-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one

1.2 Other means of identification

Product number -
Other names Intermediate for Zopiclone II

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:43200-81-3 SDS

43200-81-3Synthetic route

6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3.4-b]pyrazin-5-yl acetate

6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3.4-b]pyrazin-5-yl acetate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With sulfuric acid In ethanol for 3h; Reflux;88.7%
6-(5-chloro-2-pyridyl)-5,7-dioxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine
43200-82-4

6-(5-chloro-2-pyridyl)-5,7-dioxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Stage #1: 6-(5-chloro-2-pyridyl)-5,7-dioxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine With potassium borohydride In 1,4-dioxane at 10 - 15℃; for 0.5h;
Stage #2: With water In 1,4-dioxane for 6h;
87.4%
With potassium borohydride; water In tetrahydrofuran at -10 - 5℃; for 3h; Large scale;70%
With potassium borohydride; potassium carbonate In 1,4-dioxane; water; N,N-dimethyl-formamide at 13℃; pH=11; Reagent/catalyst; Solvent; pH-value;95.5 g
With sodium hydroxide; sodium tetrahydroborate In water at 0 - 5℃; for 4 - 5h; Product distribution / selectivity;
(-)-Zopiclone
138680-08-7

(-)-Zopiclone

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Stage #1: (-)-Zopiclone With trifluoroacetic acid In dichloromethane for 18h; Heating / reflux;
Stage #2: With water; sodium hydrogencarbonate In dichloromethane at 0℃; pH=7.5 - 8; Product distribution / selectivity;
70%
Stage #1: (-)-Zopiclone With trifluoroacetic acid In dichloromethane for 18h; Heating / reflux;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water at 0℃; pH=7.5 - 8; Product distribution / selectivity;
70%
Stage #1: (-)-Zopiclone With hydrogenchloride; water In methanol at 41℃; for 11h;
Stage #2: With sodium hydrogencarbonate In methanol; water at 10 - 15℃; Product distribution / selectivity;
41.24%
Stage #1: (-)-Zopiclone With hydrogenchloride; water In methanol at 41℃; for 11h;
Stage #2: With sodium hydrogencarbonate In methanol; water at 10 - 15℃; Product distribution / selectivity;
41.24%
With hydrogenchloride; water at 70℃; for 3h;
(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-18-4

(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

B

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-20-8

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With phosphate buffer; Candida antarctica lipase B Chirazyme-L2; triethylamine In water; toluene at 60℃; for 96h; pH=7;
(+/-)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-17-3

(+/-)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

B

(S)-(+)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-19-5

(S)-(+)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With phosphate buffer; Candida antarctica lipase B Novozym 435 In water; toluene at 60℃; for 96h; pH=7;
(R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate D-(+)-O,O'-dibenzoyltartaric acid salt
144025-94-5

(R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate D-(+)-O,O'-dibenzoyltartaric acid salt

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Stage #1: (R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate D-(+)-O,O'-dibenzoyltartaric acid salt With water; sodium hydrogencarbonate In dichloromethane; acetonitrile at 25 - 30℃; for 0.75h;
Stage #2: With hydrogenchloride; formic acid; water at 0 - 68℃; for 4h; Product distribution / selectivity;
(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-18-4

(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(R)-5-(chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4-b]pyrazine
1151528-25-4

(R)-5-(chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4-b]pyrazine

B

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

C

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-20-8

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With propan-1-ol; triethylamine; Novozyme 435 In toluene at 45℃; for 16 - 24h; Purification / work up; Enzymatic reaction; Resolution of racemate;A n/a
B n/a
C n/a
2,3-pyrazinedicarboxylic anhydride
4744-50-7

2,3-pyrazinedicarboxylic anhydride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: dmap; triethylamine / 5,5-dimethyl-1,3-cyclohexadiene / 13 h / 0 °C / Reflux
2.1: potassium borohydride / 1,4-dioxane / 0.5 h / 10 - 15 °C
2.2: 6 h
View Scheme
Multi-step reaction with 3 steps
1.1: toluene / 2.5 h / 20 - 52 °C
1.2: 1 h / 10 - 15 °C
2.1: dichloromethane / 1 h / Heating / reflux
2.2: 0.75 - 1 h / 25 - 30 °C / Heating / reflux
3.1: sodium hydroxide; sodium tetrahydroborate / water / 4 - 5 h / 0 - 5 °C
View Scheme
Multi-step reaction with 2 steps
1: propionic acid anhydride / 1 h / 60 - 105 °C
2: potassium borohydride; water / tetrahydrofuran / 3 h / -10 - 5 °C / Large scale
View Scheme
5-chloro-2-pyridylamine
1072-98-6

5-chloro-2-pyridylamine

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: dmap; triethylamine / 5,5-dimethyl-1,3-cyclohexadiene / 13 h / 0 °C / Reflux
2.1: potassium borohydride / 1,4-dioxane / 0.5 h / 10 - 15 °C
2.2: 6 h
View Scheme
Multi-step reaction with 3 steps
1.1: toluene / 2.5 h / 20 - 52 °C
1.2: 1 h / 10 - 15 °C
2.1: dichloromethane / 1 h / Heating / reflux
2.2: 0.75 - 1 h / 25 - 30 °C / Heating / reflux
3.1: sodium hydroxide; sodium tetrahydroborate / water / 4 - 5 h / 0 - 5 °C
View Scheme
Multi-step reaction with 3 steps
1: isopropyl alcohol / 5 h / Reflux; Large scale
2: 1 h / Reflux; Large scale
3: sulfuric acid / ethanol / 3 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: propionic acid anhydride / 1 h / 60 - 105 °C
2: potassium borohydride; water / tetrahydrofuran / 3 h / -10 - 5 °C / Large scale
View Scheme
zopiclon
43200-80-2

zopiclon

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: water; acetonitrile / 3 - 4.5 h / 25 - 80 °C / Resolution of racemate
2.1: water; sodium hydrogencarbonate / dichloromethane; acetonitrile / 0.75 h / 25 - 30 °C
2.2: 4 h / 0 - 68 °C
View Scheme
3-((5-chloropyridin-2-yl)carbamoyl)pyrazine-2-carboxylic acid
43200-83-5

3-((5-chloropyridin-2-yl)carbamoyl)pyrazine-2-carboxylic acid

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: dichloromethane / 1 h / Heating / reflux
1.2: 0.75 - 1 h / 25 - 30 °C / Heating / reflux
2.1: sodium hydroxide; sodium tetrahydroborate / water / 4 - 5 h / 0 - 5 °C
View Scheme
2-Chloroethyl chloroformate
627-11-2

2-Chloroethyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-17-3

(+/-)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 7h;98%
With pyridine In dichloromethane at 0 - 20℃; for 7h;98%
With pyridine In dichloromethane at 20℃; for 7h;
carbonochloridic acid 1-chloro-ethyl ester
50893-53-3

carbonochloridic acid 1-chloro-ethyl ester

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(1-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(1-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; for 4h;98%
With pyridine
2,2,2-trichloro-1,1-dimethylethoxychloroformate
66270-36-8

2,2,2-trichloro-1,1-dimethylethoxychloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(1,1-dimethyl-2,2,2-trichloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(1,1-dimethyl-2,2,2-trichloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; for 2h;98%
With pyridine
6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

2,2,2-Trichloroethyl chloroformate
17341-93-4

2,2,2-Trichloroethyl chloroformate

(+/-)-6-(5-chloropyridin-2-yl)-7-oxo-5-(2,2,2-trichloroethyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

(+/-)-6-(5-chloropyridin-2-yl)-7-oxo-5-(2,2,2-trichloroethyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 5h;98%
With pyridine In dichloromethane at 0 - 20℃; for 5h;98%
4-methylpiperazine-1-carbonyl chloride monohydrochloride
55112-42-0

4-methylpiperazine-1-carbonyl chloride monohydrochloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

zopiclon
43200-80-2

zopiclon

Conditions
ConditionsYield
Stage #1: 4-methylpiperazine-1-carbonyl chloride monohydrochloride With triethylamine In dichloromethane at 5℃; for 0.416667h;
Stage #2: dmap In dichloromethane for 0.0166667 - 0.0333333h;
Stage #3: 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one In dichloromethane at 20℃; for 7h; Product distribution / selectivity; Heating / reflux;
95%
With triethylamine; dmap In 2-methylpropyl acetate at 80℃; for 5.5h; Product distribution / selectivity;91.7%
Stage #1: 4-methylpiperazine-1-carbonyl chloride monohydrochloride With triethylamine In ethyl acetate for 0.166667h;
Stage #2: 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one; dmap In ethyl acetate at 60℃; for 7.5h; Product distribution / selectivity;
90%
Isopropenyl chloroformate
57933-83-2

Isopropenyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

6-(5-chloropyridin-2-yl)-7-oxo-5-(2-propenyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine
862210-86-4

6-(5-chloropyridin-2-yl)-7-oxo-5-(2-propenyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; for 6h;93%
6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
148891-53-6

6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With diisobutylaluminium hydride In toluene at -15℃; for 2h; Temperature;92.6%
benzoyl chloride
98-88-4

benzoyl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

benzoic acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

benzoic acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 4h;89%
butyryl chloride
141-75-3

butyryl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 5h;87%
carbonochloridic acid, chloromethyl ester
22128-62-7

carbonochloridic acid, chloromethyl ester

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-18-4

(+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 17h;86%
With pyridine In dichloromethane at 25℃; for 17h;86%
With pyridine In dichloromethane at 0 - 20℃; for 17h;86%
acetyl chloride
75-36-5

acetyl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3.4-b]pyrazin-5-yl acetate

6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3.4-b]pyrazin-5-yl acetate

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 5h;85%
4-methyl-piperazine-1-carbonyl chloride
39539-66-7

4-methyl-piperazine-1-carbonyl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

zopiclon
43200-80-2

zopiclon

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃; for 3h; Reflux;80%
With dmap; triethylamine In acetonitrile at 60 - 65℃; for 1.5h; Large scale;80.9%
Stage #1: 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at -10 - 35℃;
Stage #2: 4-methyl-piperazine-1-carbonyl chloride In N,N-dimethyl-formamide; mineral oil at -10 - 20℃; Product distribution / selectivity;
78.81%
Stage #1: 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With sodium hydride In N,N-dimethyl-formamide at -10℃;
Stage #2: 4-methyl-piperazine-1-carbonyl chloride In N,N-dimethyl-formamide at -10 - 20℃; for 3h; Product distribution / selectivity;
78.81%
With sodium hydride In N,N-dimethyl-formamide Product distribution / selectivity;
6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

3-hydroxymethyl-pyrazine-2-carboxylic acid N-(5-chloro-pyridin-2-yl)-amide
1122549-43-2

3-hydroxymethyl-pyrazine-2-carboxylic acid N-(5-chloro-pyridin-2-yl)-amide

Conditions
ConditionsYield
With sodium tetrahydroborate In 1,4-dioxane; water at 10 - 15℃; for 2h;75.2%
Vinyl chloroformate
5130-24-5

Vinyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-6-(5-chloropyridin-2-yl)-7-oxo-5-(vinyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine
190369-20-1

(+/-)-6-(5-chloropyridin-2-yl)-7-oxo-5-(vinyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
With pyridine In dichloromethane at 25℃; for 10h;75%
4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(p-nitrophenyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(p-nitrophenyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; for 21h;55%
With pyridine
di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

6-(5-chloropyridin-2-yl)-7-oxo-5-(N-succinimidyloxycarbonyloxi)-5,6-dihydropyrrolo[3,4b]pyrazine

6-(5-chloropyridin-2-yl)-7-oxo-5-(N-succinimidyloxycarbonyloxi)-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
With pyridine; triethylamine In acetonitrile at 0 - 20℃; for 18h;40%
phenyl chloroformate
1885-14-9

phenyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

C18H11ClN4O4

C18H11ClN4O4

Conditions
ConditionsYield
With (R)-6-benzyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole; triethylamine In dichloromethane at 20℃; Catalytic behavior; enantioselective reaction;35%
2-nitrophenyl chloroformate
50353-00-9

2-nitrophenyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(o-nitrophenyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

(+/-)-7-(o-nitrophenyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

Conditions
ConditionsYield
With pyridine
carbonochloridic acid, chloromethyl ester
22128-62-7

carbonochloridic acid, chloromethyl ester

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-20-8

(S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

B

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
Stage #1: carbonochloridic acid, chloromethyl ester; 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With pyridine In dichloromethane at 25℃; for 17h;
Stage #2: With Candida antarctica lipase (fraction B) - octadecyl-Sepabeads; sodium phosphate In 1,4-dioxane; water at 25℃; pH=7;
2-Chloroethyl chloroformate
627-11-2

2-Chloroethyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(S)-(+)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
508169-19-5

(S)-(+)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

B

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
Stage #1: 2-Chloroethyl chloroformate; 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With pyridine In dichloromethane at 25℃; for 7h;
Stage #2: With Candida antarctica lipase (fraction B) - octadecyl-Sepabeads; sodium phosphate In 1,4-dioxane; water at 25℃; pH=7;
acetyl chloride
75-36-5

acetyl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

B

acetic acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

acetic acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Conditions
ConditionsYield
Stage #1: acetyl chloride; 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With pyridine In dichloromethane at 25℃; for 5h;
Stage #2: With Candida antarctica lipase (fraction B) - octadecyl-Sepabeads; sodium phosphate In 1,4-dioxane; water at 37℃; pH=7;
butyryl chloride
141-75-3

butyryl chloride

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

B

(7S)-6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one

(7S)-6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one

C

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

D

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

butyric acid 6-(5-chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Conditions
ConditionsYield
Stage #1: butyryl chloride; 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With pyridine In dichloromethane at 25℃; for 5h;
Stage #2: With Candida antarctica lipase (fraction B) - octadecyl-Sepabeads; sodium phosphate In 1,4-dioxane; water at 25℃; pH=7; Title compound not separated from byproducts;
Vinyl chloroformate
5130-24-5

Vinyl chloroformate

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

A

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

(R)-6-(5-chloropyridin-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine

B

(S)-6-(5-chloropyridin-2-yl)-7-oxo-5-(vinyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

(S)-6-(5-chloropyridin-2-yl)-7-oxo-5-(vinyloxycarbonyloxy)-5,6-dihydropyrrolo[3,4b]pyrazine

Conditions
ConditionsYield
Stage #1: Vinyl chloroformate; 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one With pyridine In dichloromethane at 25℃; for 10h;
Stage #2: With Candida antarctica lipase (fraction B) - octadecyl-Sepabeads; sodium phosphate In 1,4-dioxane; water at 25℃; pH=7;
6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
43200-81-3

6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

eszopiclone
138729-47-2

eszopiclone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 86 percent / pyridine / CH2Cl2 / 17 h / 20 °C
2: Candida antarctica lipase B Chirazyme-L2; phosphate buffer; triethylamine / toluene; H2O / 96 h / 60 °C / pH 7
3: 90 percent / acetone / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: (R)-6-tert-butyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole; triethylamine / dichloromethane / 0 °C
2: acetonitrile / 2 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: dmap; calcium oxide / dichloromethane; N,N-dimethyl-formamide / 10 - 30 °C
2: water; acetonitrile / 3 - 4.5 h / 25 - 80 °C / Resolution of racemate
3: water; sodium hydrogencarbonate / 3 - 4 h / 25 - 30 °C
View Scheme

43200-81-3Relevant academic research and scientific papers

Preparation method of zopiclone intermediate

-

, (2020/06/17)

The invention provides a preparation method of zopiclone. According to the method, anhydride is used as a reaction solvent, pyrazine-2,3-dianhydride and 2-amino-5-chloropyridine are synthesized into 6-(5-chloro-2-pyridyl)-5,7-dioxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine in one step, so that the process is simplified, the obtained product is high in yield and purity, production conditions and environment friendliness are achieved, and the method is suitable for industrial production.

Zopiclone intermediate preparation method

-

Paragraph 0023-0025, (2019/01/14)

The invention relates to a zopiclone intermediate preparation method and belongs to the technical field of chemical synthesis. The preparation method includes the steps of firstly, adding 2-formyl pyrazine carboxylic acid shown in the formula V in an alcohols solvent, dropping 2-amino-5-chlorine pyridine shown in the formula VI, performing reflux reaction to obtain the formula III; under stirringof the formula III with acetic anhydride, heating up to reflux reaction to obtain the formula II; under stirring of the formula II with inorganic acid in ethyl alcohol, heating up to reflux reaction.With the preparation method of zopiclone intermediate 6-(5-chlorine pyridine-2-base)-5H-pyrrole(3,4-B)pyrazine05,7(6H)-diketone, the shortcoming about exceeding of open loop impurities and over-reduced impurities due to the fact that an existing process reduction reaction process is hard to control is overcome.

A method for producing zopiclone

-

, (2017/01/05)

The invention relates to a preparation method of zopiclone for improving sleeping, belonging to the field of medicines. In the preparation process of 6-(5-chlro-2-pyridyl)-5, 7-dioxo-5, 6-dihydropyrrolo[3, 4-b] pyrazine, namely a compound 3, by taking DMAP (dimethylaminopyridine) as a catalyst, in the presence of triethylamine, cyclization is directly carried out to synthesize an intermediate 3. The crude product yield is 85%, the yield is improved, the operation is simplified, and irritant reagents such as acetic anhydride, thionyl chloride, ethyl chloroformate and the like are not used, thereby facilitating production, facilitating recovery of xylene as a solvent and reducing emission of three wastes. Zopiclone is further synthesized by the compound 3. The method is concise in whole line, simple and convenient to operate and more suitable for industrialized production.

Preparation method of pyrazine hydroxyl pyrrolidone compound

-

Paragraph 0040-0043, (2017/02/09)

The present invention discloses a preparation method of a pyrazine hydroxyl pyrrolidone compound. The preparation method comprises the steps of: (a) adjusting the pH value of water to higher than 7 with inorganic base to obtain an aqueous solution of inorganic base, or adjusting the pH value of a water-containing organic solvent to higher than 7 with inorganic base to obtain an inorganic base water-containing organic solvent solution, and dissolving potassium borohydride or sodium borohydride; and (2) dissolving the raw materials in a solvent in a container to obtain a raw material solution, controlling the reaction temperature at 11-15 DEG C, adding a potassium borohydride solution or a sodium borohydride solution, and reacting to obtain the pyrazine hydroxyl pyrrolidone compound. According to the method, potassium borohydride or sodium borohydride is added in the form of solution into the reaction system, and the control of feed rate by temperature indication avoids instantaneous release of excessive hydrogen. The method solves in the problem of instantaneous release of excessive hydrogen due to difficulty in controlling a single dosage in the traditional methods, and has the characteristics of simpleness, safe and reliable production, high yield and good product quality.

Process for synthesis and purification of anhydrous crystalline S-zopiclone

-

Page/Page column 9, (2009/06/27)

Process for synthesis and purification of anhydrous crystalline S-zopiclone for the preparation of enantiomerically pure {S)-5-{chloromethyloxycarbonyloxy)-6-{5-chloropyrid-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine (S)-(I).

Process for Preparation of Dextrorotatory Isomer of 6-(5- chloro-pyrid-2-yl)-5-[(4-methyl -1-piperazinyl) carbonyloxy] -7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyrazine (Eszopiclone)

-

Page/Page column 5; 10, (2009/08/16)

Disclosed herein is the process for preparation of 6-(5-chloro-pyrid-2-yl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine (Zopiclone), its resolution to get the dextrorotatory isomer of formula (I) substantially free of R(?) enantiomer and recovery of key raw material i.e. 6-(5-chloro pyrid-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4-b]pyrazine from the R-isomer of Zopiclone followed by conversion of the recovered compound to get pure Eszopiclone (I) in high yield and high purity.

PROCESS FOR PREPARATION OF DEXTROROTATORY ISOMER OF 6-(5-CHLORO-PYRID-2-YI)-5-[(4-METHYL -1-PIPERAZINYL) CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO [3,4-B] PYRAZINE (ESZOPICLONE)

-

Page/Page column 22; 23, (2009/06/27)

Disclosed herein is the process for preparation of 6-(5-chloro-pyrid-2-yl)-5-[(4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyrazine (Zopiclone), its resolution to get the dextrorotatory isomer of formula (I) substantially free of R (-) enantiomer and recovery of key raw material i.e. 6-(5-chloro pyrid-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo [3,4-b] pyrazine from the R-isomer of Zopiclone followed by conversion of the recovered compound to get pure Eszopiclone (I) in high yield and high purity.

IMPROVED PROCESS FOR THE PREPARATION OF ZOPICLONE AND IT'S ENANTIOMERICALLY ENRICHED ISOMER

-

, (2008/12/08)

Present invention relates to an improved process for the preparation of Zopiclone and its enantiomerically enriched isomer (Eszopiclone). 6-(5-Chloropyridin-2- yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo [3,4-b] pyrazine is reacted with 1-chloro- carbonyl-4-methylpiperazine in the presence of alkali earth metal carbonates, hydroxides or oxides in a solvent medium to give Zopiclone. It is reacted with optically active acid in a mixture of water and water miscible organic solvent followed by work up to give Eszopiclone. The present invention also relates to process for the conversion of (R) or (S) Zopiclone to 6-(5-chloropyrid-2-yl)-5-hydroxy-7-oxo-5,6-dihydro- pyrrolo- [3,4-b] - pyrazine of the intermediate which can be converted to racemic Zopiclone.

Process for the preparation of eszopiclone

-

Page/Page column 5, (2008/12/06)

The invention relates to a process for making of 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo-[3,4-b] pyrazin-5-yl-4-methyl piperazine-1-carboxylate, also known as zopiclone. The invention further describes an effective method for resolving of zopiclone into its enantiomers (eszopiclone and (R)-zopiclone) and also provides a method of recycling of (R)-zopiclone.

Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone

Solares, Laura F.,Diaz, Monica,Brieva, Rosario,Sanchez, Victor M.,Bayod, Miguel,Gotor, Vicente

, p. 2577 - 2582 (2007/10/03)

The lipase from Candida antarctica B catalyzes the enantioselective hydrolysis of (±)-6-(5-chloropyridin-2-yl)-7-chloromethyloxycarbonyloxy-6,7- dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one, a useful intermediate in the synthesis of (S)-(+)-zopiclone. This enzyme also catalyzes the resolution of the corresponding 2-chloroethylcarbonate derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 43200-81-3